ESRP1 and breast carcinoma: Our result of decreased CD44v splice variants in CRC tumor cells are supported by findings in metastatic breast cancer cells that changed the expression from CD44v to CD44s variant isoforms on the cell surface after depletion of ESRP1 [16].